期刊文献+

程序性细胞死亡因子4在肿瘤中的研究进展 被引量:1

Research progress of programmed cell death 4 in tumors
原文传递
导出
摘要 程序性细胞死亡因子4(PDCD4)为新近发现的抑癌基因,其表达受PDCD4基因甲基化、多种微小RNA的抑制.PDCD4编码的蛋白质可增强多种肿瘤细胞对抗肿瘤药物的敏感性,抑制肿瘤的发生发展和侵袭转移进程,在多种肿瘤中发挥重要作用,有望成为临床上判断肿瘤预后的重要指标. Programmed cell death 4 (PDCD4) is a newly discovered tumor suppressor gene, whose expression is regulated by methylation of PDCD4 gene and many kinds of microRNAs.Protein of PDCD4 enco-ding can improve the sensitivity of tumor cells to anticancer agents, inhibit tumor development and metastasis process, and play an important role in a variety of tumors.It is expected to be a clinical indicator to determine the prognosis of tumor.
出处 《国际肿瘤学杂志》 CAS 2017年第7期512-515,共4页 Journal of International Oncology
基金 国家自然科学基金(81603439) 安徽省中医药科技项目(2016zy86)
关键词 肿瘤 程序性细胞死亡因子4 Neoplasms Programmed cell death 4
  • 相关文献

参考文献3

二级参考文献18

  • 1Chen Y, KnOsel T, Kristiansen G, Pietas A, Garber ME, Matsuhashi S, Ozaki I, Petersen I. Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis. J Pathol 2003; 200:640-646
  • 2Wang Q, Sun Z, Yang HS. Downregulation of tumor suppressor Pdcd4 promotes invasion and activates both beta-catenin/Tcf and AP-1- dependent transcription in colon carcinoma cells. Oncogene 2008; 27:1527-1535
  • 3Jansen AP, Camalier CE, Stark C, Colburn NH. Characterization of programmed cell death 4 in multiple human cancers reveals a novel enhancer of drug sensitivity. Mol Cancer Ther 2004; 3: 103-110
  • 4Zhang XW, Jiang JF, Xu B. Differentiation-inducing action of 10-hydroxycamptothecin on human hepatoma Hep G2 cells. Acta Pharmacol Sin 2000; 21: 364-368
  • 5Yang HS, Jansen AP, Komar AA, Zheng X, Merrick WC, Costes S, Lockett SJ, Sonenberg N, Colburn NH. The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation. Mol Cell Biol 2003; 23:26-37
  • 6Stalberg P, Lopez-Egido JR, Wang S, Gobl A, Oberg K, Skogseid B. Differentially expressed cDNAs in PLCbeta3-induced tumor suppression in a human endocrine pancreatic tumor cell line: activation of the human mismatch repair protein 3 gene. Biochem Biophys Res Commun 2001; 281:227-231
  • 7Bird Adrian.Perceptions of epigenetics. Nature . 2007
  • 8Rawson James B,Manno Michael,Mrkonjic Miralem,Daftary Darshana,Dicks Elizabeth,Buchanan Daniel D,Younghusband H Banfield,Parfrey Patrick S,Young Joanne P,Pollett Aaron,Green Roger C,Gallinger Steven,McLaughlin John R,Knight Julia A,Bapat Bha.Promoter methylation of Wnt antagonists DKK1 and SFRP1 is associated with opposing tumor subtypes in two large populations of colorectal cancer patients. Carcinogenesis . 2011
  • 9Wang Xiao,Li Xuebing,Fan Fengjuan,Jiao Shi,Wang Lingdi,Zhu Lu,Pan Yi,Wu Guohao,Ling Zhi-Qiang,Fang Jing,Chen Yan.PAQR3 plays a suppressive role in the tumorigenesis of colorectal cancers. Carcinogenesis . 2012
  • 10Yuhui Jiang,Xiaoduo Xie,Yixuan Zhang,Xiaolin Luo,Xiao Wang,Fengjuan Fan,Dawei Zheng,Zhenzhen Wang,Yan Chen.Regulation of G-Protein Signaling by RKTG via Sequestration of the Gβγ Subunit to the Golgi Apparatus. Molecular and Cellular Probes . 2010

共引文献29

同被引文献5

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部